CN103734842B - A kind of Angelica Keiskei beverage with effect of lowering blood sugar and preparation method thereof - Google Patents
A kind of Angelica Keiskei beverage with effect of lowering blood sugar and preparation method thereof Download PDFInfo
- Publication number
- CN103734842B CN103734842B CN201310700968.0A CN201310700968A CN103734842B CN 103734842 B CN103734842 B CN 103734842B CN 201310700968 A CN201310700968 A CN 201310700968A CN 103734842 B CN103734842 B CN 103734842B
- Authority
- CN
- China
- Prior art keywords
- ashitaba
- extract
- beverage
- preparation
- hawthorn
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000013361 beverage Nutrition 0.000 title claims abstract description 20
- 238000002360 preparation method Methods 0.000 title claims description 17
- 239000008280 blood Substances 0.000 title description 13
- 210000004369 blood Anatomy 0.000 title description 13
- 230000000694 effects Effects 0.000 title description 6
- 241001105098 Angelica keiskei Species 0.000 title 1
- 239000000284 extract Substances 0.000 claims abstract description 40
- 230000002218 hypoglycaemic effect Effects 0.000 claims abstract description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 24
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 20
- 235000020717 hawthorn extract Nutrition 0.000 claims abstract description 18
- 229940109275 cyclamate Drugs 0.000 claims abstract description 14
- HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid Chemical compound OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 claims abstract description 14
- 239000001509 sodium citrate Substances 0.000 claims abstract description 12
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims abstract description 12
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 claims abstract description 11
- 235000010241 potassium sorbate Nutrition 0.000 claims abstract description 11
- 229940069338 potassium sorbate Drugs 0.000 claims abstract description 11
- 239000004302 potassium sorbate Substances 0.000 claims abstract description 11
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 10
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 10
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 10
- 239000011718 vitamin C Substances 0.000 claims abstract description 10
- 239000004320 sodium erythorbate Substances 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 8
- 239000000203 mixture Substances 0.000 claims description 10
- 241001092040 Crataegus Species 0.000 claims description 6
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims description 6
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims description 6
- 235000009685 Crataegus X maligna Nutrition 0.000 claims description 6
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims description 6
- 235000009486 Crataegus bullatus Nutrition 0.000 claims description 6
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims description 6
- 235000009682 Crataegus limnophila Nutrition 0.000 claims description 6
- 235000004423 Crataegus monogyna Nutrition 0.000 claims description 6
- 235000002313 Crataegus paludosa Nutrition 0.000 claims description 6
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims description 6
- 238000000265 homogenisation Methods 0.000 claims description 5
- 239000008213 purified water Substances 0.000 claims description 5
- 229960001790 sodium citrate Drugs 0.000 claims description 5
- 235000013399 edible fruits Nutrition 0.000 claims description 2
- 239000003814 drug Substances 0.000 abstract description 4
- 235000013305 food Nutrition 0.000 abstract description 4
- DQFBYFPFKXHELB-UHFFFAOYSA-N Chalcone Natural products C=1C=CC=CC=1C(=O)C=CC1=CC=CC=C1 DQFBYFPFKXHELB-UHFFFAOYSA-N 0.000 abstract description 3
- 235000005513 chalcones Nutrition 0.000 abstract description 3
- 238000011160 research Methods 0.000 abstract description 3
- 150000001789 chalcones Chemical class 0.000 abstract description 2
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 2
- 241000699670 Mus sp. Species 0.000 description 13
- 206010012601 diabetes mellitus Diseases 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 235000003599 food sweetener Nutrition 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 239000003765 sweetening agent Substances 0.000 description 5
- 235000007106 Crataegus suborbiculata Nutrition 0.000 description 4
- 241000073432 Crataegus suborbiculata Species 0.000 description 4
- 235000013202 a hawthorn Nutrition 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000003472 antidiabetic agent Substances 0.000 description 2
- 229940126678 chinese medicines Drugs 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 201000001421 hyperglycemia Diseases 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 239000012948 isocyanate Substances 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 235000010378 sodium ascorbate Nutrition 0.000 description 2
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 2
- 229960005055 sodium ascorbate Drugs 0.000 description 2
- 229940126673 western medicines Drugs 0.000 description 2
- AJERVVHSERWGFL-UXBLZVDNSA-N (e)-1-[3-(2-hydroperoxy-3-methylbut-3-enyl)-2-hydroxy-4-methoxyphenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one Chemical compound OC1=C(CC(OO)C(C)=C)C(OC)=CC=C1C(=O)\C=C\C1=CC=C(O)C=C1 AJERVVHSERWGFL-UXBLZVDNSA-N 0.000 description 1
- 244000061520 Angelica archangelica Species 0.000 description 1
- 241000208173 Apiaceae Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000017701 Endocrine disease Diseases 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- 208000017170 Lipid metabolism disease Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000022329 Protein metabolism disease Diseases 0.000 description 1
- 108091006299 SLC2A2 Proteins 0.000 description 1
- 108091006300 SLC2A4 Proteins 0.000 description 1
- ZSJLQEPLLKMAKR-UHFFFAOYSA-N Streptozotocin Natural products O=NN(C)C(=O)NC1C(O)OC(CO)C(O)C1O ZSJLQEPLLKMAKR-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 208000020450 carbohydrate metabolism disease Diseases 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000013118 diabetic mouse model Methods 0.000 description 1
- 208000016097 disease of metabolism Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 208000017745 inborn carbohydrate metabolic disease Diseases 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 description 1
- 229960003105 metformin Drugs 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 235000010352 sodium erythorbate Nutrition 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- ZSJLQEPLLKMAKR-GKHCUFPYSA-N streptozocin Chemical compound O=NN(C)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O ZSJLQEPLLKMAKR-GKHCUFPYSA-N 0.000 description 1
- 229960001052 streptozocin Drugs 0.000 description 1
- DQFBYFPFKXHELB-VAWYXSNFSA-N trans-chalcone Chemical compound C=1C=CC=CC=1C(=O)\C=C\C1=CC=CC=C1 DQFBYFPFKXHELB-VAWYXSNFSA-N 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/52—Adding ingredients
- A23L2/60—Sweeteners
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Non-Alcoholic Beverages (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种具有降血糖功效的明日叶饮料,其特征在于它是由以下质量百分比的原料制成:明日叶提取液15-50%,山楂提取液10-30%,柠檬酸钠0.1-0.6%,甜蜜素0.01-0.03%,维生素C?0.01-0.04%﹑D-异抗坏血酸钠0.005-0.01%﹑山梨酸钾0.01-0.02%,余量为水。本发明公开的一种明日叶降血糖饮料的配方是从几十种具有降血糖作用的“药食两用”中药中通过反复研究而形成,配方所制成的饮料色泽光亮,澄明度高,香味独特,富含丰富的明日叶查尔酮。The present invention relates to a Ashitaba beverage with hypoglycemic effect, which is characterized in that it is made of the following raw materials in mass percent: Ashitaba extract 15-50%, hawthorn extract 10-30%, sodium citrate 0.1- 0.6%, cyclamate 0.01-0.03%, vitamin C? 0.01-0.04%, D-sodium erythorbate 0.005-0.01%, potassium sorbate 0.01-0.02%, the balance is water. The formula of Ashitaba hypoglycemic drink disclosed by the present invention is formed through repeated researches from dozens of "medicine and food dual-purpose" traditional Chinese medicines with hypoglycemic effect. The beverage made from the formula has bright color and high clarity. Distinctive scent rich in Ashitaba Chalcones.
Description
技术领域technical field
本发明涉及一种具有降血糖功效的明日叶饮料及其制备方法。The invention relates to an ashitaba drink with hypoglycemic effect and a preparation method thereof.
背景技术Background technique
糖尿病是一种因胰岛素分泌不足,引起脂肪﹑蛋白质﹑碳水化合物代谢紊乱等内分泌失调的慢性代谢性疾病。目前降糖西药多为口服降糖药物和注射降糖药物两类。口降糖西药毒副作用大,不宜长期服用,某些中药降糖作用好,但中药对熬制有一定要求,并且携带不方便,口感不好,这些无疑给糖尿病患者带来许多困难。Diabetes is a chronic metabolic disease characterized by endocrine disorders such as fat, protein, and carbohydrate metabolism disorders due to insufficient insulin secretion. At present, most western medicines for hypoglycemia fall into two categories: oral hypoglycemic drugs and injection hypoglycemic drugs. Oral hypoglycemic Western medicines have serious side effects and are not suitable for long-term use. Some Chinese medicines have good hypoglycemic effects, but Chinese medicines have certain requirements for boiling, and they are inconvenient to carry and taste bad. These undoubtedly bring many difficulties to diabetic patients.
明日叶是伞形科当归属多年生的草本植物,近年研究发现明日叶中含有非常罕见的查尔酮,有良好的降血糖防糖尿病等诸多功效。据报道,明日叶查尔酮可上调肝脏葡萄糖转运体2和骨骼肌葡萄糖转运体4蛋白表达水平,降低空腹血糖和胰岛素水平,改善糖尿病胰岛素抵抗状况。Ashitaba is a perennial herbaceous plant belonging to the Umbelliferae family Angelica. Recent studies have found that Ashitaba contains a very rare chalcone, which has many effects such as lowering blood sugar and preventing diabetes. According to reports, ashitaba chalcone can up-regulate the expression levels of liver glucose transporter 2 and skeletal muscle glucose transporter 4, reduce fasting blood glucose and insulin levels, and improve insulin resistance in diabetes.
目前降血糖保健饮料的研发不多,并且以明日叶为原料而制成的降血糖饮料还未见报道,而且明日叶属于“药食两用”食材,制成的明日叶饮料风味独特,方便饮用。At present, there are not many researches and developments on blood sugar-lowering health drinks, and the blood-sugar-lowering drinks made from Ashitaba have not been reported yet, and Ashitaba is a "dual-purpose food and medicine" ingredient, and the Ashitaba drink made has a unique flavor and is convenient. drink.
发明内容Contents of the invention
本发明所要解决的技术问题是以明日叶为主要原料,辅以山楂提取液,用甜味剂和酸味剂调配,制成口感良好,香味独特,具有降血糖功效的明日叶饮料。The technical problem to be solved by the present invention is to use ashitaba as the main raw material, supplemented with hawthorn extract, blended with sweetener and sour agent, to make ashitaba drink with good taste, unique fragrance and hypoglycemic effect.
本发明的技术方案是:Technical scheme of the present invention is:
一种具有降血糖功效的明日叶饮料,其特征在于它是由以下质量百分比的原料制成:明日叶提取液15-50%,山楂提取液10-30%,柠檬酸钠0.1-0.6%,甜蜜素0.01-0.03%,维生素C0.01-0.04%﹑D-异抗坏血酸钠0.005-0.01%﹑山梨酸钾0.01-0.02%,余量为水。A kind of Ashitaba beverage with hypoglycemic effect is characterized in that it is made of the following raw materials in mass percentage: Ashitaba extract 15-50%, hawthorn extract 10-30%, sodium citrate 0.1-0.6%, Cyclamate 0.01-0.03%, vitamin C 0.01-0.04%, D-sodium erythorbate 0.005-0.01%, potassium sorbate 0.01-0.02%, and the balance is water.
所述甜味剂是甜蜜素。The sweetener is cyclamate.
一种具有降血糖功效的明日叶饮料的制备方法,其特征在于,它的步骤如下:A preparation method of Ashitaba beverage with hypoglycemic effect, is characterized in that, its steps are as follows:
(1)明日叶提取液制备:明日叶干叶加20倍重量的水于90-95℃下水浴半小时,提取2次,合并二次提取液,制成明日叶提取液。(1) Preparation of Ashitaba extract: Add 20 times the weight of Ashitaba dry leaves to a water bath at 90-95°C for half an hour, extract twice, and combine the second extracts to make Ashitaba extract.
(2)山楂提取液制备:山楂干果实10倍重量的水于90-95℃下水浴提取2小时,制成山楂提取液。(2) Preparation of hawthorn extract: extract 10 times the weight of dried hawthorn fruit in a water bath at 90-95°C for 2 hours to prepare a hawthorn extract.
(3)将明日叶提取液﹑山楂提取液按比例混合,加入柠檬酸钠﹑甜蜜素﹑维生素C﹑D-异抗坏血酸钠﹑山梨酸钾,再加入纯净水混合均匀,在温度20-85℃﹑功率100-400W的条件下进行超声均质30-60min,在80-90℃下,灭菌10-15min,灌装冷却后制成。(3) Mix Ashitaba extract and hawthorn extract in proportion, add sodium citrate, cyclamate, vitamin C, D-sodium erythorbate, potassium sorbate, add purified water and mix evenly, at a temperature of 20-85°C ﹑Under the condition of power 100-400W, conduct ultrasonic homogenization for 30-60 minutes, sterilize at 80-90 ℃ for 10-15 minutes, fill and cool.
本发明公开的一种明日叶降血糖饮料的配方是从几十种具有降血糖作用的“药食两用”中药中通过反复研究而形成,配方所制成的饮料色泽光亮,澄明度高,香味独特,富含丰富的明日叶查尔酮。本发明中所述甜味剂是适于糖尿病人食用的甜蜜素。The formula of Ashitaba hypoglycemic drink disclosed by the present invention is formed through repeated researches from dozens of "medicine and food dual-purpose" traditional Chinese medicines with hypoglycemic effect. The beverage made from the formula has bright color and high clarity. Distinctive scent rich in Ashitaba Chalcones. The sweetener described in the present invention is cyclamate suitable for diabetics.
本发明的特色之处是:1.本饮料以适用糖尿病人食用的甜味剂甜蜜素为甜味剂,故适合糖尿病人食用;2.本饮料所选取的原料是药食两用的明日叶和山楂,不添加任何色素和香精,保留其天然的色泽和香味,长期服用没有任何副作用,并且工艺简单,适合工业生产。The characteristics of the present invention are: 1. This beverage uses sweetener cyclamate suitable for diabetics as sweetener, so it is suitable for diabetics to eat; 2. The selected raw material of this beverage is ashitaba for both medicine and food And hawthorn, do not add any pigment and flavor, retain its natural color and fragrance, long-term use without any side effects, and the process is simple, suitable for industrial production.
用本发明的配方制备的明日叶饮料,经动物实验,对糖尿病模型的小鼠具有较明显的降血糖功效并且对正常小鼠无明显作用。The ashitaba beverage prepared with the formula of the present invention has obvious hypoglycemic effect on diabetic model mice through animal experiments and has no obvious effect on normal mice.
具体实施方式detailed description
实施例1Example 1
一种降血糖明日叶饮料,它是由以下原料组成:以1000g为总量,明日叶提取液200g,山楂提取液200g,柠檬酸钠5g,甜蜜素0.3g,维生素C0.4g﹑D-异抗坏血酸钠0.1g﹑山梨酸钾0.2g,余量为水。A hypoglycemic Ashitaba beverage, which is composed of the following raw materials: 1000g as the total amount, 200g of Ashitaba extract, 200g of hawthorn extract, 5g of sodium citrate, 0.3g of cyclamate, 0.4g of vitamin C, D-isocyanate Sodium ascorbate 0.1g, potassium sorbate 0.2g, the balance is water.
所述降血糖明日叶饮料制备方法步骤如下:The preparation method steps of described hypoglycemic Ashitaba beverage are as follows:
(1)明日叶提取液制备:明日叶干叶加20倍重量水于90-95℃下水浴半小时,提取2次,合并二次提取液,制成明日叶提取液。(1) Preparation of Ashitaba extract: add 20 times the weight of Ashitaba dry leaves to water bath at 90-95°C for half an hour, extract twice, and combine the second extracts to make Ashitaba extract.
(2)山楂提取液制备:山楂干果加10倍重量水于90-95℃下水浴提取2小时,制成山楂提取液。(2) Preparation of hawthorn extract: Add 10 times the weight of water to the dried hawthorn and extract in a water bath at 90-95°C for 2 hours to make a hawthorn extract.
(3)将明日叶提取液﹑山楂提取液按比例混合,加入柠檬酸钠﹑甜蜜素﹑维生素C﹑D-异抗坏血酸钠﹑山梨酸钾,再加入纯净水混合均匀,在温度20-85℃﹑功率100-400W的条件下进行超声均质30-60min,在80-90℃下,灭菌10-15min,灌装冷却后制成。(3) Mix Ashitaba extract and hawthorn extract in proportion, add sodium citrate, cyclamate, vitamin C, D-sodium erythorbate, potassium sorbate, add purified water and mix evenly, at a temperature of 20-85°C ﹑Under the condition of power 100-400W, conduct ultrasonic homogenization for 30-60min, sterilize at 80-90℃ for 10-15min, fill and cool.
实施例2Example 2
一种降血糖明日叶饮料,它是由以下原料组成:以1000g为总量,明日叶提取液300g,山楂提取液100g,柠檬酸钠4.5g,甜蜜素0.25g,维生素C0.3g﹑D-异抗坏血酸钠0.1g﹑山梨酸钾0.2g,余量为水。A hypoglycemic Ashitaba beverage, which is made up of the following raw materials: 1000g is the total amount, 300g of Ashitaba extract, 100g of hawthorn extract, 4.5g of sodium citrate, 0.25g of cyclamate, vitamin C0.3g, D- Sodium erythorbate 0.1g, potassium sorbate 0.2g, and the balance is water.
所述降血糖明日叶饮料制备方法步骤如下:The preparation method steps of described hypoglycemic Ashitaba beverage are as follows:
(1)明日叶提取液制备:明日叶干叶加20重量倍水于90-95℃下水浴半小时,提取2次,合并两次提取液,制成明日叶提取液。(1) Preparation of Ashitaba extract: Add 20 times the weight of Ashitaba dry leaves to a water bath at 90-95°C for half an hour, extract twice, and combine the two extracts to make Ashitaba extract.
(2)山楂提取液制备:山楂干果加10倍重量水于90-95℃下水浴提取2小时,制成山楂提取液。(2) Preparation of hawthorn extract: Add 10 times the weight of water to the dried hawthorn and extract in a water bath at 90-95°C for 2 hours to make a hawthorn extract.
(3)将明日叶提取液﹑山楂提取液按比例混合,加入柠檬酸钠﹑甜蜜素﹑维生素C﹑D-异抗坏血酸钠﹑山梨酸钾,再加入纯净水混合均匀,在温度20-85℃﹑功率100-400W的条件下进行超声均质30-60min,在80-90℃下,灭菌10-15min,灌装冷却后制成。(3) Mix Ashitaba extract and hawthorn extract in proportion, add sodium citrate, cyclamate, vitamin C, D-sodium erythorbate, potassium sorbate, add purified water and mix evenly, at a temperature of 20-85°C ﹑Under the condition of power 100-400W, conduct ultrasonic homogenization for 30-60min, sterilize at 80-90℃ for 10-15min, fill and cool.
实施例3Example 3
一种降血糖明日叶饮料,它是由以下原料组成:以1000g为总量,明日叶提取液400g,山楂提取液100g,柠檬酸钠5g,甜蜜素0.25g,维生素C0.35g﹑D-异抗坏血酸钠0.1g﹑山梨酸钾0.2g,余量为水。A hypoglycemic ashitaba beverage, which is made up of the following raw materials: 1000g as total amount, 400g of ashitaba extract, 100g of hawthorn extract, 5g of sodium citrate, 0.25g of cyclamate, 0.35g of vitamin C, D-isocyanate Sodium ascorbate 0.1g, potassium sorbate 0.2g, the balance is water.
所述降血糖明日叶饮料制备方法步骤如下:The preparation method steps of described hypoglycemic Ashitaba beverage are as follows:
(1)明日叶提取液制备:明日叶干叶加20倍重量水于90-95℃下水浴半小时,提取2次,合并两次提取液,制成明日叶提取液。(1) Preparation of Ashitaba extract: Add 20 times the weight of Ashitaba dry leaves to water bath at 90-95°C for half an hour, extract twice, and combine the two extracts to make Ashitaba extract.
(2)山楂提取液制备:山楂干果加10倍重量水于90-95℃下水浴提取2小时,制成山楂提取液。(2) Preparation of hawthorn extract: Add 10 times the weight of water to the dried hawthorn and extract in a water bath at 90-95°C for 2 hours to make a hawthorn extract.
(3)将明日叶提取液﹑山楂提取液按比例混合,加入柠檬酸钠﹑甜蜜素﹑维生素C﹑D-异抗坏血酸钠﹑山梨酸钾,再加入纯净水混合均匀,在温度20-85℃﹑功率100-400W的条件下进行超声均质30-60min,在80-90℃下,灭菌10-15min,灌装冷却后制成。(3) Mix Ashitaba extract and hawthorn extract in proportion, add sodium citrate, cyclamate, vitamin C, D-sodium erythorbate, potassium sorbate, add purified water and mix evenly, at a temperature of 20-85°C ﹑Under the condition of power 100-400W, conduct ultrasonic homogenization for 30-60min, sterilize at 80-90℃ for 10-15min, fill and cool.
明日叶饮料对糖尿病小鼠降血糖功效评价Evaluation of the hypoglycemic effect of Ashitaba beverage on diabetic mice
(1)糖尿病小鼠造模及分组(1) Modeling and grouping of diabetic mice
ICR小鼠适应性饲养3d后,将小鼠分成造模组和空白组,禁食16小时后造模组小鼠腹腔注射0.1mg/g·bw链脲菌素的柠檬酸钠缓冲溶液,空白组注射相同剂量的生理盐水,3天后测量血糖,选取血糖高于11.1mmol/L小鼠24只分成3组,选取空白组小鼠16只分成空白组与空白对照组2组。After the ICR mice were fed adaptively for 3 days, the mice were divided into a model group and a blank group. After 16 hours of fasting, the mice in the model group were intraperitoneally injected with 0.1 mg/g bw streptozotocin sodium citrate buffer solution, and the blank group was injected intraperitoneally. The same dose of normal saline was injected into the control group, blood glucose was measured 3 days later, 24 mice with blood glucose higher than 11.1mmol/L were selected and divided into 3 groups, and 16 mice in the blank group were selected and divided into two groups: blank group and blank control group.
(2)降糖试验(2) Hypoglycemic test
空白组与模型组灌胃生理盐水,空白对照组与试验组灌胃所制饮料,阳性组灌胃二甲双胍溶液,各组自由饮食。连续灌胃3周,血糖仪测定空腹血糖,结果见表1。The blank group and the model group were intragastrically administered normal saline, the blank control group and the test group were intragastrically administered the prepared beverage, the positive group were intragastrically administered metformin solution, and each group was free to eat and drink. After 3 consecutive weeks of gavage, fasting blood glucose was measured with a blood glucose meter. The results are shown in Table 1.
(3)实验结果(3) Experimental results
各指标以表示,用SPSS统计软件进行组间均数差异F检验。Each indicator is Indicates that the F test for the mean difference between groups was carried out with SPSS statistical software.
表1明日叶饮料对小鼠血糖变化的影响(mmol/l,)The influence of table 1 Ashitaba beverage on the change of blood sugar in mice (mmol/l, )
注:a:p<0.01,与空白组比较;b:p<0.01,与模型组比较Note: a: p<0.01, compared with the blank group; b: p<0.01, compared with the model group
由表1可知,空白对照组小鼠血糖值与空白组比较几乎没有变化,高血糖模型组的小鼠血糖值比空白组显著升高(p<0.01),说明小鼠高血糖模型的建立比较成功。阳性组的血糖值比模型组有所下降(p<0.05),试验组的血糖值比模型组明显下降(p<0.01),说明明日叶饮料具有明显的降血糖作用并且对正常小鼠没有影响。It can be seen from Table 1 that the blood sugar level of the mice in the blank control group has almost no change compared with the blank group, and the blood sugar level of the mice in the hyperglycemia model group is significantly higher than that of the blank group (p<0.01), which shows that the establishment of a hyperglycemia model in mice is relatively success. The blood sugar level of the positive group was lower than that of the model group (p<0.05), and the blood sugar level of the test group was significantly lower than that of the model group (p<0.01), indicating that the ashitaba drink had a significant hypoglycemic effect and had no effect on normal mice .
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310700968.0A CN103734842B (en) | 2013-12-18 | 2013-12-18 | A kind of Angelica Keiskei beverage with effect of lowering blood sugar and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310700968.0A CN103734842B (en) | 2013-12-18 | 2013-12-18 | A kind of Angelica Keiskei beverage with effect of lowering blood sugar and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103734842A CN103734842A (en) | 2014-04-23 |
CN103734842B true CN103734842B (en) | 2016-05-18 |
Family
ID=50491977
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310700968.0A Active CN103734842B (en) | 2013-12-18 | 2013-12-18 | A kind of Angelica Keiskei beverage with effect of lowering blood sugar and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103734842B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105167049A (en) * | 2015-08-13 | 2015-12-23 | 江苏碧云天农林科技有限公司 | Angelica keiskei medicinal beverage for lowering hypertension, hyperglycemia and hyperlipidemia and production process thereof |
CN108552383A (en) * | 2018-06-11 | 2018-09-21 | 黑龙江德盛粮食深加工有限公司 | A kind of corn stigma dandelion herb tea and preparation method thereof |
CN108967787A (en) * | 2018-08-08 | 2018-12-11 | 中山市海枣椰农业科技有限公司 | A kind of India's ivy gourd leaf beverage and preparation method thereof with effect of lowering blood sugar |
CN110179916A (en) * | 2019-07-16 | 2019-08-30 | 哈尔滨膳宝酒业有限公司 | Reducing blood lipid, Traditional Chinese medicine for reducing blood glucose oral solution made of a kind of linseed oil fructus arctii |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102640958A (en) * | 2012-03-13 | 2012-08-22 | 刘方旭 | Preparation technique of compound angelica utilis and orange juice drink and preparation method thereof |
CN103230064A (en) * | 2013-05-14 | 2013-08-07 | 兰州大学 | Hawthorn compound drink |
-
2013
- 2013-12-18 CN CN201310700968.0A patent/CN103734842B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102640958A (en) * | 2012-03-13 | 2012-08-22 | 刘方旭 | Preparation technique of compound angelica utilis and orange juice drink and preparation method thereof |
CN103230064A (en) * | 2013-05-14 | 2013-08-07 | 兰州大学 | Hawthorn compound drink |
Non-Patent Citations (2)
Title |
---|
山楂的药理作用与临床应用;李建华等;《中国药物滥用防治杂志》;20111130;第17卷(第6期);第334-336、338页 * |
无糖山楂饮料的研制;郭雪霞等;《中国食品添加剂》;20060131(第1期);第99页摘要,左栏第1-2段,右栏第1段,第100页左栏2.2、2.3部分,第102页右栏第4段 * |
Also Published As
Publication number | Publication date |
---|---|
CN103734842A (en) | 2014-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104872558A (en) | Low-glycemic-index brewing porridge and preparation method thereof | |
CN103734842B (en) | A kind of Angelica Keiskei beverage with effect of lowering blood sugar and preparation method thereof | |
CN103598595B (en) | Instant mulberry leaf wheat gluten slices and preparation method thereof | |
CN104432035B (en) | The health nutrient composition and method of making the same of enhancing immunity and application | |
CN106880058B (en) | Sugar-free syrup and preparation method thereof | |
CN102132716B (en) | Special biscuit for diabetics and preparation method thereof | |
CN105747235A (en) | Diet composition able to improve symptoms of metabolic syndrome | |
CN101416743B (en) | Potentilla anserina L. rice flour food and production method thereof | |
CN105285644A (en) | Vinegar beverage rich in dietary fiber and preparation method thereof | |
CN105124482A (en) | Sugarfree health-care konjac and water chestnut cakes and preparation method thereof | |
CN104872775B (en) | A kind of compound fat-reducing solid beverage of green tea tea polysaccharide and application | |
CN104366509A (en) | Nutritional meal replacement powder for blood glucose regulation and preparation method thereof | |
CN103340274A (en) | Chewing gum with health-care function | |
CN107223981B (en) | Composition containing soybean polypeptide argatroxin and preparation method thereof | |
CN104381556A (en) | Konjac jelly and production technology thereof | |
CN115444127A (en) | A zero-sucrose instant white fungus soup with weight-loss and lipid-lowering effects | |
CN104957342A (en) | Low-sugar golden camellia candy | |
JP6273440B2 (en) | GLP-1 production promoter, DPPIV inhibitor and glucose absorption inhibitor | |
CN102067907A (en) | Highland barley rice milk beverage | |
KR20170055366A (en) | A composition for preventing or treating obesity comprising taraxacum coreanum root extract | |
CN104365811A (en) | Corn biscuit of green tea | |
CN102475328A (en) | Low-calorie sea buckthorn beverage | |
CN105012627B (en) | Stomach strengthening and digestion promoting capsule and preparation method thereof | |
JP5845240B2 (en) | Gold wire continuous fermentation product, production method and use thereof | |
CN103271172A (en) | Health-care blending corn oil and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |